View Older Stories View More Recent Stories

Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 12, 2017 07:04AM Cantor Fitzgerald Reiterates Overweight on The Priceline Group (PCLN) Following 1Q Checks
Apr 11, 2017 09:29AM Pre-Open Movers 04/11: (SALE) (TNXP) (MXWL) Higher; (CYTX) (AFSI) (SLP) Lower (more...)
Apr 11, 2017 07:30AM INAP Signs Customized Colocation and Network Agreement in the Company's Flagship Dallas Data Center
Apr 11, 2017 06:38AM TherapeuticsMD (TXMD): FDA Letter Implies PDUFA Date May Slide - Cantor
Apr 11, 2017 06:16AM Cantor Fitzgerald Downgrades Wix.com (WIX) to Neutral on Valuation
Apr 10, 2017 05:54PM After-Hours Stock Movers 09/01: (SALE) (MXWL) (AUPH) Higher; (CYTX) (SLP) (SEAC) Lower (more...)
Apr 10, 2017 04:11PM Cantor Fitzgerald Starts Aurinia Pharmaceuticals (AUPH) at Overweight
Apr 10, 2017 01:55PM Cantor Fitzgerald Reiterates Neutral Rating and $190 PT on Humana (HUM); 1Q Earnings Preview for 5/3 Report
Apr 7, 2017 07:38AM AngioDynamics (ANGO) PT Raised to $21 at Cantor Fitzgerald Following Investor Day
Apr 6, 2017 06:41AM Cantor Fitzgerald Reiterates Overweight Rating and $31 PT on Supernus Pharma (SUPN) Following Final FDA Approval of Trokendi XR for Migranes
Apr 6, 2017 06:36AM Jazz Pharmaceuticals (JAZZ) PT Raised to $197 at Cantor Fitzgerald; 'Xyrem Settlement Could Raise Ceiling for JAZZ Stock'
Apr 6, 2017 05:46AM Cantor Fitzgerald Downgrades Teladoc (TDOC) to Neutral
Apr 5, 2017 11:20AM Cantor Fitzgerald Reiterates Overweight and $24 PT on Corbus Pharmaceuticals (CRBP); 'Pivotal Systemic Sclerosis (SSc) Study Unveiled'
Apr 5, 2017 09:01AM Cantor Fitzgerald Reiterates Overweight Rating and $25 PT on Corvus Pharmaceuticals (CRVS) Following CPI-444 Data Results
Apr 5, 2017 08:58AM Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH) Ahead of 1Q Report
Apr 4, 2017 03:02PM Freddie Mac Prices $1.3 Billion Multifamily K-Deal, KF29
Apr 4, 2017 07:42AM Paratek Pharmaceuticals (PRTK): Omadacycline Hits Primary Endpoints - Cantor
Apr 4, 2017 07:33AM Cantor Fitzgerald Reiterates Overweight Rating and $34 PT on TherapeuticsMD (TXMD); 'Compelling TX-001 Data' Continues
Apr 4, 2017 06:55AM Agile Therapeutics (AGRX) PT Raised to $9 at Cantor Fitzgerald Following KOL Call on Twirla
Apr 3, 2017 09:10AM Rodin Global Property Trust Offering Declared Effective by the US Securities and Exchange Commission
Mar 31, 2017 10:39AM NantHealth (NH) PT Lowered to $13 at Cantor Fitzgerald Following 4Q
Mar 31, 2017 09:30AM Pre-Open Movers 03/31: (SORL) (BBRY) (BDSI) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
Mar 30, 2017 06:15PM After-Hours Stock Movers 03/30: (AKTX) (VJET) (HIIQ) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
Mar 30, 2017 04:25PM Orexigen Therapeutics (OREX) Enters $20M ATM Offering with Cantor Fitzgerald
Mar 30, 2017 04:07PM Cantor Fitzgerald Starts Health Insurance Innovations (HIIQ) at Overweight; Sees a Double in the Stock
Mar 30, 2017 04:05PM Cantor Fitzgerald Starts HealthEquity, Inc (HQY) at Overweight
Mar 30, 2017 11:51AM Corbus Pharmaceuticals (CRBP) PT Raised to $24 at Cantor Fitzgerald Following Positive Study Data
Mar 30, 2017 07:32AM Paratek Pharmaceuticals (PRTK): Raising PT After Non Deal Roadshow - Cantor
Mar 29, 2017 05:05PM Seabridge Gold Announces $14.3 Million Bought Deal Offering of Common Shares and a Concurrent $20.0 Million Bought Deal Offering of Flow-Through Shares
Mar 29, 2017 10:26AM Cantor Fitzgerald Adds Lance Vegna to Lead Global Portfolio Solutions Team
Mar 29, 2017 07:37AM IHS Markit (INFO) PT Raised to $41 at Cantor Fitzgerald Following 1Q
Mar 29, 2017 06:48AM Amazon.com (AMZN) PT Raised to $970 at Cantor Fitzgerald; Wave of Store Closings and Rise in Private Labels is 'Big Opportunity'
Mar 27, 2017 04:56PM Harmony Merger Corp. Stockholders Approve Extension to Consummate Initial Business Combination
Mar 27, 2017 08:34AM CRH Medical (CRHM) PT Raised to $10 at Cantor Fitzgerald; Reiterates Overweight
Mar 27, 2017 06:10AM Snap (SNAP) Quiet Period Ends, Recap Of Ratings And PTs From Sell-Side
Mar 27, 2017 06:04AM Cantor Fitzgeralds Reiterates Overweight Rating and $15 PT on eHealth (EHTH) Following Management's Completion of Strategic Process
Mar 24, 2017 08:45AM The Energy Report Examines How As Uranium Price Turns, Insiders Stock Up on Energy Fuels
Mar 24, 2017 08:05AM Cantor Fitzgerald Reiterates Overweight on Accenture (ACN) Following 2Q
Mar 22, 2017 07:34AM Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
Mar 22, 2017 07:26AM Cantor Fitzgerald Reiterates Overweight on NeoGenomics (NEO) After Meeting with Management
Mar 22, 2017 07:07AM Cantor Fitzgerald Reiterates Overweight Rating and $175 PT on Expedia (EXPE); Checks In-Line, Travel Ban Impact 'Limited'
Mar 22, 2017 06:07AM Avex Designs Launches New Website For Cantor Fitzgerald Wealth Partners
Mar 21, 2017 03:00PM Cantor Fitzgerald Investment Advisors Acquires Business of Efficient Market Advisors
Mar 21, 2017 07:11AM Accenture (ACN): 2Q17 Earnings Preview - Cantor
Mar 21, 2017 06:44AM Cantor Fitzgerald Reiterates Outperform Rating and $6 PT on Amarin Corp. (AMRN) Following Positive PCSK9 Data Results
Mar 20, 2017 04:05PM Aurinia Closes US$173.1 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
Mar 20, 2017 11:36AM Harmony Merger Corp. Announces Filing of Proxy Supplement
Mar 17, 2017 08:17AM Cantor Fitzgerald Remains Bullish on eHealth (EHTH)
Mar 17, 2017 08:06AM Cantor Fitzgerald Maintains Neutral Rating and $51 PT on Alkermes plc (ALKS) Following the Start of 'ALKS 8700 Phase 3 Trial'
View More Recent Stories View Older Stories